Brooklyn ImmunoTherapeutics (BTX) Competitors $0.42 -0.03 (-5.97%) As of 01/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BTX vs. ALFIW, and NLOKShould you be buying Brooklyn ImmunoTherapeutics stock or one of its competitors? The main competitors of Brooklyn ImmunoTherapeutics include Alfi (ALFIW), and NortonLifeLock (NLOK). These companies are all part of the "information" sector. Brooklyn ImmunoTherapeutics vs. Alfi NortonLifeLock Alfi (NASDAQ:ALFIW) and Brooklyn ImmunoTherapeutics (NYSE:BTX) are both information companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Does the MarketBeat Community prefer ALFIW or BTX? Alfi and Brooklyn ImmunoTherapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlfiN/AN/ABrooklyn ImmunoTherapeuticsOutperform VotesNo VotesUnderperform Votes103100.00% Does the media prefer ALFIW or BTX? In the previous week, Brooklyn ImmunoTherapeutics had 1 more articles in the media than Alfi. MarketBeat recorded 1 mentions for Brooklyn ImmunoTherapeutics and 0 mentions for Alfi. Alfi's average media sentiment score of 0.00 equaled Brooklyn ImmunoTherapeutics'average media sentiment score. Company Overall Sentiment Alfi Neutral Brooklyn ImmunoTherapeutics Neutral Which has better earnings and valuation, ALFIW or BTX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlfi$200.68KN/AN/AN/AN/ABrooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-0.19 Is ALFIW or BTX more profitable? Company Net Margins Return on Equity Return on Assets AlfiN/A N/A N/A Brooklyn ImmunoTherapeutics N/A N/A N/A Do institutionals and insiders believe in ALFIW or BTX? 26.0% of Brooklyn ImmunoTherapeutics shares are held by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryBrooklyn ImmunoTherapeutics beats Alfi on 3 of the 4 factors compared between the two stocks. Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTX vs. The Competition Export to ExcelMetricBrooklyn ImmunoTherapeuticsTelevision Broadcasting IndustryInformation SectorNYSE ExchangeMarket Cap$24.84M$24.84M$5.27B$19.90BDividend YieldN/AN/A3.69%3.63%P/E Ratio-0.19N/A8.2834.24Price / SalesN/AN/A5.5817.10Price / CashN/AN/AN/A20.32Price / BookN/AN/AN/A5.78Net IncomeN/AN/AN/A$1.00B7 Day Performance40.73%40.73%6.18%2.23%1 Month Performance68.81%68.81%9.67%4.72%1 Year Performance-69.84%-69.84%-8.63%18.80% Brooklyn ImmunoTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTXBrooklyn ImmunoTherapeuticsN/A$0.42-6.0%N/A-69.8%$24.84MN/A-0.19N/AGap DownHigh Trading VolumeALFIWAlfiN/AN/AN/AN/A$0.00$200,684.000.0040NLOKNortonLifeLock1.5033 of 5 stars$26.90-0.8%N/A+17.2%$15.37B$2.82B18.81N/A Related Companies and Tools Related Companies ALFIW Competitors NLOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BTX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTX Stock Alerts